| Product Code: ETC11479087 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cancer Profiling and Pathways Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cancer Profiling and Pathways Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cancer Profiling and Pathways Market - Industry Life Cycle |
3.4 Israel Cancer Profiling and Pathways Market - Porter's Five Forces |
3.5 Israel Cancer Profiling and Pathways Market Revenues & Volume Share, By Profiling Type, 2021 & 2031F |
3.6 Israel Cancer Profiling and Pathways Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Cancer Profiling and Pathways Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Cancer Profiling and Pathways Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Israel Cancer Profiling and Pathways Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing adoption of personalized medicine in cancer treatment |
4.2.3 Technological advancements in cancer profiling and pathways analysis |
4.3 Market Restraints |
4.3.1 Regulatory challenges in implementing cancer profiling technologies |
4.3.2 High cost associated with cancer profiling and pathways analysis |
4.3.3 Limited awareness and accessibility of advanced cancer profiling services in Israel |
5 Israel Cancer Profiling and Pathways Market Trends |
6 Israel Cancer Profiling and Pathways Market, By Types |
6.1 Israel Cancer Profiling and Pathways Market, By Profiling Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cancer Profiling and Pathways Market Revenues & Volume, By Profiling Type, 2021 - 2031F |
6.1.3 Israel Cancer Profiling and Pathways Market Revenues & Volume, By Genomic Profiling, 2021 - 2031F |
6.1.4 Israel Cancer Profiling and Pathways Market Revenues & Volume, By Epigenetic Profiling, 2021 - 2031F |
6.2 Israel Cancer Profiling and Pathways Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Cancer Profiling and Pathways Market Revenues & Volume, By Personalized Treatment, 2021 - 2031F |
6.2.3 Israel Cancer Profiling and Pathways Market Revenues & Volume, By Drug Development, 2021 - 2031F |
6.3 Israel Cancer Profiling and Pathways Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Cancer Profiling and Pathways Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.3 Israel Cancer Profiling and Pathways Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4 Israel Cancer Profiling and Pathways Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Israel Cancer Profiling and Pathways Market Revenues & Volume, By NGS (Next-Generation Sequencing), 2021 - 2031F |
6.4.3 Israel Cancer Profiling and Pathways Market Revenues & Volume, By Microarrays, 2021 - 2031F |
7 Israel Cancer Profiling and Pathways Market Import-Export Trade Statistics |
7.1 Israel Cancer Profiling and Pathways Market Export to Major Countries |
7.2 Israel Cancer Profiling and Pathways Market Imports from Major Countries |
8 Israel Cancer Profiling and Pathways Market Key Performance Indicators |
8.1 Number of research collaborations between healthcare institutions and technology providers for cancer profiling |
8.2 Adoption rate of personalized cancer treatment strategies in Israel |
8.3 Number of clinical trials incorporating cancer profiling and pathway analysis technologies |
9 Israel Cancer Profiling and Pathways Market - Opportunity Assessment |
9.1 Israel Cancer Profiling and Pathways Market Opportunity Assessment, By Profiling Type, 2021 & 2031F |
9.2 Israel Cancer Profiling and Pathways Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Cancer Profiling and Pathways Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Cancer Profiling and Pathways Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Israel Cancer Profiling and Pathways Market - Competitive Landscape |
10.1 Israel Cancer Profiling and Pathways Market Revenue Share, By Companies, 2024 |
10.2 Israel Cancer Profiling and Pathways Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here